Donald A. Molony, MD
Molony DA. Annual zoledronic acid did not increase renal abnormalities at 2 years in postmenopausal women with osteoporosis. Ann Intern Med. 2008;149:JC6–8. doi: 10.7326/0003-4819-149-12-200812160-02008
Download citation file:
Published: Ann Intern Med. 2008;149(12):JC6-8.
Endocrine and Metabolism, Metabolic Bone Disorders, Nephrology.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use